[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"transurethral-resection-of-bladdertumors\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:transurethral-resection-of-bladdertumors":33},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100655931","feasibility-of-hisa-during-turbt-for-nmibc-100655931",false,"NCT07817173","Feasibility of HISA During TURBT for NMIBC","A Pilot Study Using Hyperthermic Irrigation Followed by Intravesical Chemotherapy in Patients With Low- to Intermediate-Risk Non-Muscle Invasive Bladder Cancer","Inclusion Criteria:\n\n* Male or female patients\n* Age from 18 to 89 years old\n* Visual diagnosis of a papillary tumor(s) ≤ 3 cm\n* Transurethral resection of bladder tumor (TURBT)\n* Eastern Cooperative Oncology Group (ECOG) performance status grade 0-2\n* Glomerular filtration rate (GFR) ≥ 30 mL\u002Fmin\n\nExclusion Criteria:\n\n* Ages less than 18 years of age\n* Pregnant women\n* Prisoners\n* Patients with evidence of distant metastasis\n* Patients with histologically confirmed high-risk NMIBC prior to and after TURBT\n* Patients with prior carcinoma is situ diagnosis\n* Patients with an active infection defined as documented urinary tract infection based on preoperative urine analysis or urine culture\n* Immunosuppression defined as a patient with leukopenia or taking any active immunosuppressive medication\n* Patients that had an intraoperative perforation during TURBT\n* Patients participating in another clinical trial with this urologic cancer diagnosis\n* Postoperative bladder instillation failure defined as the inability to deliver and maintain the planned volume of instilled fluid within the bladder for at least 30 minutes","ALL","18 Years","89 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this prospective pilot study is to evaluate the safety and feasibility of using heated saline during bladder tumor surgery in patients with non-muscle invasive bladder cancer.\n\nThe main questions it aims to answer are:\n\nCan heated saline be given during bladder tumor removal surgery safely?\n\nDoes using heated saline keep the bladder tumor from coming back?\n\nResearchers will compare the heated saline to room temperature saline to see if the heated saline works to prevent the bladder tumor from coming back.\n\nParticipants will:\n\n* Have heated saline or room temperature saline during bladder tumor surgery\n* Visit the clinic at 2 weeks, 3 and 6 months after bladder tumor surgery\n* Complete questionnaires about quality of their life and symptoms before and after surgery\n* Provide urine samples to test your urine at each visit before and after surgery\n* To have a cystoscopy to check your bladder for tumors",[27,28,29,30,31,32,33,34,35],"Bladder Cancer","Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)","Non-muscle Invasive Bladder Cancer (NMIBC)","Non-Muscle Invasive Bladder Neoplasms","Non-muscle Invasive Bladder Cancer","Bladder Cancer (BC)","Transurethral Resection of Bladdertumors","Transurethral Resection of the Bladder","Non-Muscle Invasive Bladder Carcinoma","NOT_YET_RECRUITING","2026-09-08",{"date":39,"type":40},"2026-09-14","ACTUAL",{"date":42,"type":21},"2026-08-15",{"date":44,"type":21},"2030-05-31",{"name":46,"class":47},"CAMC Health System","OTHER"]